Weekly Roundups

The Week in Health: Going Forward and Backward on Mexican Healthcare

By Miriam Bello | Fri, 11/08/2019 - 15:08

Efforts to improve Mexico’s healthcare system are starting to form but many complications show up. Meanwhile, R&D in healthcare works to create a better life for us all.

Ready for more? This is the Week in Health!


DEA discovers Mexican cartels have managed to send adulterated medicine to the US. Among the discovered anomalies, the DEA found pills contaminated with fentanyl. Over the years, several deaths have been attributed to this synthetic opioid. 

While President López Obrador continues to ensure that medicine is properly supplied to all healthcare institutions, Baja California faces shortages with just 35 percent of medical supplies.

The government announces the creation of the Health University of Mexico City. The goal of this University is to educate medical staff with a focus on the community.

In Nuevo Leon, the reform to article 48 of the State’s Health Law gives doctors the right to conscientiously object to treat patients.

The Federal Economic Competition Commission (COFECE) started an investigation on monopolistic practices in laboratories and blood banks that would involve around 15 players.

R&D in Mexico reveals that Pre-Exposure Prophylaxis (PREP) can reduce the risk of a sexual infection by 97 percent. The private sector in Mexico has access to PREP pills already, but the price is much higher than what the government is willing to pay for.


A study confirms that genetic causes of certain diseases may be different in African people. This discovery makes possible the analysis of different genes that can help researchers identify new therapies for existing health problems all over the world.  

Miriam Bello Miriam Bello Senior Journalist and Industry Analyst